Hostname: page-component-745bb68f8f-b6zl4 Total loading time: 0 Render date: 2025-01-09T08:40:51.194Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluating the effectiveness of methylphenidate with a combination of magnesium, zinc and calcium for the treatment of patients with ADHD in the city of Zahedan

Published online by Cambridge University Press:  23 March 2020

M. Firouzkouhi Moghaddam ,
A.H. Heidari Poor ,
M. Khosravi  and
T. Rakhshani
M. Firouzkouhi Moghaddam*
Affiliation:
Zahedan University of Medical Science, Psychiatry, Zahedan, Iran
A.H. Heidari Poor
Affiliation:
Rozbeh Hospital, Psychiatry, Tehran, Iran
M. Khosravi
Affiliation:
Zahedan University of Medical Science, Psychiatry, Zahedan, Iran
T. Rakhshani
Affiliation:
Shiraz University of Medical Science, Public Health, Shiraz, Iran
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

This study aimed to investigate the therapeutic effect of a combination of magnesium, calcium and zinc as a complementary treatment in a population of the children with ADHD in Zahedan.

Material and method

In this clinical trial, 40 patients with ADHD aged 6 to 12. The simple convenience sampling was done and the patients were randomly divided into two groups of receiving methylphenidate plus magnesium + zinc + calcium, and methylphenidate plus placebo.

Results

The mean severities of the symptoms in the group treated with methylphenidate plus the supplements were 40/4 ± 2/4 before the treatment, and 19/5 ± 6/1 after 8 weeks of treatment (P < 0.001).

Conclusion

This study shows that zinc, magnesium and calcium supplement is useful in the treatment of ADHD and can be used to treat patients.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Keywords

MethylphenidateAttention deficit hyperactivity disorderZincMagnesiumCalcium
Type
e-Poster viewing: child and adolescent psychiatry
Information
European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S437
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.